The Federal Trade Commission is pursuing potential antitrust violations in the pharmaceutical industry using the muscle of a left-for-dead law that was used to protect mom-and-pop grocery stores from price discrimination during the Depression.

The agency and the Department of Health and Human Services this week jointly announced a request for information on whether practices by drug manufacturers, drug wholesalers and group-purchasing organizations may be resulting in generic drug shortages and increased drug prices.